Skip to contentV
Vsee Health, Inc.
V
VSEEVsee Health, Inc. Q2 2026 · 10-Q
Revenue$1.56M$1.56M+48.0% vs Q2 2025 Net Income-$1.74M-$1.74MderivedN/M vs Q2 2025 EPS Diluted-$0.06-$0.06N/M vs Q2 2025 Gross Profit$206,153−66.5% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vsee Health, Inc. · CIK 1864531 · Engraved from SEC EDGAR
Operating Income-$2,697,326N/M Operating Cash Flowderived-$1,173,725N/M Free Cash Flowderived-$1,246,973N/M Margins · derivedGross margin13.2%−45.1 pt vs Q2 2025
Operating margin-172.7%−25.2 pt vs Q2 2025
Net margin-111.7%+136.0 pt vs Q2 2025
ended Jun 30, 2026 · filed Aug 14, 2026 · 45 d after period end